Trials / Completed
CompletedNCT00584298
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Women With Irritable Bowel Syndrome to Evaluate Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Novartis · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to provide information on feasibility and reproducibility of barostat assessments of colorectal sensory functions and compliance and their pharmacological modulation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SMS995 | |
| DRUG | Placebo |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-04-01
- First posted
- 2008-01-02
- Last updated
- 2009-05-08
Locations
7 sites across 4 countries: United States, Canada, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00584298. Inclusion in this directory is not an endorsement.